scholarly journals Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities

2013 ◽  
Vol 2 (2) ◽  
pp. 70-74
Author(s):  
M. Dennis ◽  
D. Culligan ◽  
D. Karamitros ◽  
P. Vyas ◽  
P. Johnson ◽  
...  
Keyword(s):  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Chromosome 5 ◽  
Acute Myeloid

Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high‐risk myelodysplastic syndrome

2019 ◽  
Vol 102 (3) ◽  
pp. 218-226
Author(s):  
Marie Warny ◽  
Jens Helby ◽  
Henrik Sengeløv ◽  
Børge G. Nordestgaard ◽  
Henrik Birgens ◽  
...  
Keyword(s):  
Bone Marrow ◽  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Myelodysplastic Syndrome ◽  
Myeloid Leukaemia ◽  
Telomere Length ◽  
Mononuclear Cell ◽  
Bone Marrow Mononuclear Cell ◽  
Acute Myeloid

High risk of ‘de novo’ acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects

2009 ◽  
Vol 83 (3) ◽  
pp. 270-272 ◽  
Author(s):  
Gabriela Góes Yamaguti ◽  
Gustavo Jacob Lourenço ◽  
Fernando Ferreira Costa ◽  
Carmen Silvia Passos Lima
Keyword(s):  
Cytochrome P450 ◽  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
De Novo ◽  
Gene Defects ◽  
Acute Myeloid

scholarly journals Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study

2015 ◽  
Vol 2 (1) ◽  
pp. e12-e20 ◽  
Author(s):  
Courtney D DiNardo ◽  
Naval Daver ◽  
Elias Jabbour ◽  
Tapan Kadia ◽  
Gautam Borthakur ◽  
...  
Keyword(s):  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Myelodysplastic Syndromes ◽  
Phase 1 ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document